Antibodies & immunoassays for small molecules We are a collective of passionate and eclectic immunologists and scientists coming together to unlock new possibilities in research, diagnostics and therapy through small molecule antibodies development.
Executive team
Alban Bessede, PhD Founder,
Chief Executive Officer
Born and bred in Bordeaux, Alban founded Immusmol immediately after a post-doc in Sydney. Trained in immunology, he gained expertise in small molecule antibodies doing research in oncology and neurodegeneration. This experience eventually led him to envisage their use in diagnostics and therapy.
Dominique Bodet, PhD
Study Director
Over his career, Dominique developed over 70 small molecule antibodies. Initially trained in biochemistry and immunology, he has overseen all Immusmol lab operations, from antigen design to in vivo studies, since the company inception in 2012.
Board of directors
Vincent Picq, MSc
Founder, Chairman of Schiever
Vincent Picq has been supporting Immusmol since the very beginning. At the head of a retailing group with annual sales exceeding €1.3 billion, he provides Immusmol with strategic, management, and administrative support.